In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. - Wikidata - awgldk - TriplyDB

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

http://www.wikidata.org/entity/Q36002807

about

Lithium: the pharmacodynamic actions of the amazing ion Regulation of glycogen synthase kinase-3 during bipolar mania treatment Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics Review of pharmacological treatment in mood disorders and future directions for drug development.Diabetes-associated depression: the serotonergic system as a novel multifunctional target Signal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood Disorders Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Is glycogen synthase kinase-3 a central modulator in mood regulation?PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors Abnormalities in brain structure and behavior in GSK-3alpha mutant mice RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions?Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function Potential molecular and cellular mechanism of psychotropic drugs Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.The effects of glycogen synthase kinase-3beta in serotonin neurons.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons.Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression?Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency.Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits.Novel drugs and therapeutic targets for severe mood disorders.Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.Fluoxetine regulates neurogenesis in vitro through modulation of GSK-3β/β-catenin signaling Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine.

P2860

Q22241779-8AC3275F-E793-4B7E-AA32-79D59B1A46DE Q24594534-B59AC56F-8E2C-4369-8405-6468468639FF Q24632901-08BACA67-67B2-4D50-88FE-22513558AC5E Q24685475-CA4AB0F7-55C3-4FF5-B403-449AA8761080 Q26853509-2BC5E089-F68F-40F9-9747-655F427839B5 Q26864574-FEC115B6-FFEA-46CD-BA37-C5B69F91A1D8 Q27006485-11D8B80D-C75F-4061-87AA-001341BFDBD9 Q27008843-7BBA20F0-AE3E-4E33-9F17-4D87D60AA430 Q27027115-8DD82F0B-1291-4EB0-B208-A51C8B59170F Q28069538-C3A49E42-CC7E-4905-BCF1-1737BEE25A89 Q28118906-DFF12526-5327-4CFE-82BE-7F70A8D264F8 Q28305100-3A380FE9-C934-42D4-82D7-61B5127497DA Q28508076-8FEE8329-4907-4FA4-8128-C5F982414B36 Q30464459-9BB3A09B-B99F-4755-B4FD-5C862AEBB354 Q30474415-D4DD3B07-1DAE-4D57-AD81-0FE664DBD391 Q30475816-E01D6E27-EDA0-4692-90CB-4CBE8C158DDC Q30482703-5BF24834-823C-474D-9194-85AB5E118002 Q30485018-5927419F-B4A3-4F4C-9727-5952BA06DC70 Q30495060-D094F6AC-EA1C-45E4-84A1-F346629650FA Q30495108-5814D578-3BA0-4BA0-948B-AC455A23888B Q30522548-8D32ED30-FB19-412C-BE51-13EF48E28C5B Q30630506-87EA9D0C-42BF-4CF6-AC9A-B153BD498141 Q30906677-F95A6FB3-C5D7-46C7-9F13-DEAB1F05E8A9 Q33442821-AE152AC6-36E3-4812-8CD7-26F933A268A3 Q33709399-8F3BC5A8-A0EC-4A5F-AA0A-002BACEB01FB Q33814354-7AFC60FB-1C69-46CC-BE5C-E65C7E214B78 Q34129880-A6655A18-DFD6-4E84-8D2C-2BE0E5826EE1 Q34146222-491B34C6-C077-4FA4-9979-E5A85EE041AA Q34338701-85E1C418-17B5-4839-A466-690AC01CF85D Q34389468-DDA7D23B-FDFE-493B-B086-830C23E83E76 Q34391633-522D244A-0FA4-4BDB-B213-C611503FFCA6 Q34421875-F7C8132D-3272-4511-9F0C-E54ED5CDE10A Q34449524-743EB1BB-4552-412F-B3E2-92B90BE533E5 Q34587440-92B5BC45-1A9F-4657-B7B3-D209679F1466 Q34731214-732FEE56-F14E-4211-9AAF-04E1C9F83BCA Q34732759-41AEC0B3-0519-4157-A299-2DBC1648094B Q35049564-6AEAD684-F322-4188-8595-AAEA37C5448E Q35197367-FCFEE5EB-26AA-4D3A-8A87-3676CA77D2D0 Q35224304-63A41E53-3217-44A9-9AC1-DA5ECD856191 Q35353085-1DC0A267-DD0F-490E-8BF5-AFB696DE5D86

P2860

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

http://www.wikidata.org/entity/Q36002807

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@ast

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@en

type

label

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@ast

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@en

prefLabel

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@ast

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@en

P1433

Q36002807-0A61FF05-32EA-4DFC-AEDB-381E28617CB0

P1476

Q36002807-28BDE541-5250-4E1A-BB99-E225D85200DF

P2093

Q36002807-1291F86B-6E54-45D1-91B2-C8257CE01C18

Q36002807-256B4A39-2B92-448F-9BE8-5658B01F9B02

Q36002807-2EF47549-01F6-4F6C-A085-3B4610929BC0

Q36002807-A31E3141-3B63-4E6F-8A47-AA9A9ABF8C1C

Q36002807-CA754445-C155-46A6-BC8C-CDDC104BF20D

Q36002807-CF7EEC78-5D3A-4683-B69E-44BAFD484E64

P2860

Q36002807-02A042B5-F2C9-4A63-9899-2219D190A246

Q36002807-07A6CAB5-FD26-4481-884D-5489F8E1EF80

Q36002807-1A192156-EDE7-4C34-A0BA-A6AA3BD74578

Q36002807-3F07200A-E92A-4E7C-9945-00962E3CA783

Q36002807-433C8A39-E1B9-4E4C-BC08-CEEF928EE111

Q36002807-47EF4501-25C6-4312-BB98-138DF9102A0E

Q36002807-6711F7C1-D49E-4FA5-B16A-98ABECC25A32

Q36002807-7026F57F-2BFA-4D07-ABB5-BFA928621A23

Q36002807-71239511-1D01-4115-BCE5-FAE2248D0917

Q36002807-7E36B5C2-A3FB-4117-87BC-7C42843A77D5

P2888

Q36002807-138600D7-68F3-4018-9B7B-5AABF7F9844F

P304

Q36002807-360F327B-CF56-4AC2-A0E1-8E767483E7A2

P31

Q36002807-6D1E2586-DA5D-47F2-BD66-04CBF6AD6579

P356

Q36002807-0441192A-09E6-480D-8F12-125DD85E43F7

P407

Q36002807-B0A27D9D-90A3-4020-8FC7-8BEBC879CACF

P433

Q36002807-92A009F0-959C-42CA-812E-C73B1DFA1B98

P478

Q36002807-7E8FC390-7DA9-47C1-8DD0-C6949307E137

P577

Q36002807-0F1FC738-E956-40AA-8D7E-C9DF5E744AAD

P5875

Q36002807-B5712A78-B666-4B81-A2A7-1DF11B23449B

P6179

Q36002807-94C79405-828E-4785-8023-298D7BF1CEAA

P698

Q36002807-6C1FFD8B-2E26-4760-8BE3-E6643D4987B2

P932

Q36002807-175A058D-5958-440C-BAF3-FE634B6799AC

P356

P1433

Neuropsychopharmacology

P1476

In vivo regulation of glycogen ...... ergic activity in mouse brain.

@en

P2093

Ari B Friedman

http://www.w3.org/2001/XMLSchema#string

Kelley Rosborough

http://www.w3.org/2001/XMLSchema#string

Myoung-Sun Roh

http://www.w3.org/2001/XMLSchema#string

Richard S Jope

http://www.w3.org/2001/XMLSchema#string

Wawa Zhu

http://www.w3.org/2001/XMLSchema#string

Xiaohua Li

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

A molecular mechanism for the effect of lithium on development

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

PET imaging of serotonin 1A receptor binding in depression

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

The glamour and gloom of glycogen synthase kinase-3

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

A molecular and cellular theory of depression.

Molecular targets of lithium action.

P2888

P304

1426-1431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1300439

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8660565

http://www.w3.org/2001/XMLSchema#string

P6179

1038620067

http://www.w3.org/2001/XMLSchema#string

P698

15039769

http://www.w3.org/2001/XMLSchema#string

P932

1986663

http://www.w3.org/2001/XMLSchema#string